These 4 ASX shares have more than doubled in value this year

Galaxy Resources Limited (ASX:GXY) is one of four ASX shares which have gone absolutely gangbusters this year. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although it has been a turbulent year with many ups and downs, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has still managed to carve out a solid 5% gain so far this year.

Whilst this is a good return, it pales in comparison to the returns some shares have provided for investors. Here are four shares which have more than doubled in value this year.

Afterpay Holdings Ltd (ASX: AFY)

Shareholders of this fast-growing payment company have seen its share price rise a massive 119% in 2016. Afterpay provides retailers with the ability to offer interest-free, buy now, pay later options online and in-store. The company takes a small percentage of the sale in exchange for bearing its default risk. Afterpay recently announced a deal with Super Retail Group Ltd (ASX: SUL) to bring the total number of retailers using its platform to over 1,500. I think the company has a bright future ahead of it, though it is starting to look a little expensive.

Codan Limited (ASX: CDA)

Codan designs and manufactures a wide range of electronic products, including radio communications, metal detectors, and mining technology. Its shares are up 179% this year thanks partly to an extremely strong start to FY 2017. Management recently revealed that sales in the first four months of FY 2017 were up 76% on the prior corresponding period to $74 million. Despite the rapid rise in its share price, its shares are still changing hands at just 11x forecast full year earnings. At this price Codan could be worth a closer look in my opinion.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

Clinuvel is the company behind the Scenesse treatment for Erythropoietic Protoporphyria, a rare genetic enzymatic disorder causing lifelong absolute light intolerance. The treatment is already available on prescription in a number of European countries and the company is making significant progress in its quest for FDA-approval in the United States. Although it is a niche market, the market clearly recognises that it has the potential to be very lucrative. As a result its shares are up 185% this year.

Galaxy Resources Limited (ASX: GXY)

This lithium miner has gone absolutely gangbusters this year and produced an incredible 326% gain for its shareholders. Lithium prices have risen at a strong rate thanks to growing demand for its use in batteries for smartphones, tablets, and electric cars. I wouldn't expect similar gains next year though. A recent report in the Financial Times revealed that the global market for battery chemical lithium will remain fairly balanced for the next four to five years.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »